The Tumor Differentiation module of the AI-based software mdbrain enables automated differentiation between the tumor core and surrounding marginal oedema in detected gliomas. The analysis is accessible within within a few minutes. The results are integrated as a PDF report and overlays directly into the PACS. Additionally, a direct API to radiotherapy and neurosurgery software can be provided.
Solid tumor components are differentiated based on contrast medium uptake, which allows for easy delineation and quantification of the tumor core and surrounding marginal oedema in gliomas. Additionally, changes over time (growth rate in % per year) are reliably quantified to assess potential progression.
Select a study to review AI outputs
View AI results in the deepcOS AI Evaluator
Key benefits
Time savings through automated segmentation of gliomas.
Time savings through automated follow-up monitoring of inoperable tumors.
Advantages in communication with referring physicians and patients through intuitive reports with color-coded overlays.